|Bid||61.10 x 900|
|Ask||70.72 x 900|
|Day's Range||70.57 - 72.16|
|52 Week Range||41.19 - 155.75|
|Beta (5Y Monthly)||1.66|
|PE Ratio (TTM)||49.09|
|Earnings Date||Nov 5, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||65.88|
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not gamble the hard-earned money of the people who are on the edge of poverty. Truth […]
In this article we are going to estimate the intrinsic value of Inogen, Inc. (NASDAQ:INGN) by estimating the company's...
Kaskela Law LLC has commenced an investigation of Inogen, Inc. (“Inogen” or the “Company”) (INGN) on behalf of the Company’s stockholders. Stockholders who purchased shares of Inogen’s common stock before November 8, 2017 are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (888) 715 – 1740, or via email at firstname.lastname@example.org, to discuss this investigation and their legal rights and options. Additional information about this investigation may also be requested at http://kaskelalaw.com/case/inogen/.
Inogen, Inc. , a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the Stifel 2019 Healthcare Conference in New York.
The medical technology company, which makes portable oxygen concentrators, is one of our top stocks to watch in our Charts of the Day video from last night. The stock began breaking out of a two-month base in mid-October, up from the $45 range, and, with Tuesday’s pop of $1.62 to $59.32 and after-hours move into the mid-$60’s, it has appeared poised to accelerate. Watch for the stock in the maker of aesthetic medical products and recent IPO to reach the top of the rising channel in the $45 range.
Inogen (INGN) delivered earnings and revenue surprises of 34.78% and 0.42%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply aren't very good. However, our research shows this not to be the case. In fact, when it comes to their very top picks collectively, they show a strong ability […]
Inogen, Inc. , a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release third quarter 2019 financial results after market close on Tuesday, November 5, 2019.
Shareholder rights law firm Robbins Arroyo LLP reminds investors that shareholders of Inogen filed a class action complaint against the company for alleged violations of the Securities Exchange Act of 1934 between November 8, 2017 and February 26, 2019.
Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Inogen Inc. (INGN) on behalf of long-term stockholders. Our investigating follows a class action complaint that was filed against Inogen on March 6, 2019. The complaint alleges that during the class period, defendants made false and misleading statements and/or failed to disclose adverse information regarding Inogen’s business metrics and financial prospects.
Inogen, Inc. (NASDAQ:INGN) shareholders might be concerned after seeing the share price drop 24% in the last quarter...
Sufferers of chronic obstructive pulmonary disease, asthma, lung disease, or asthma typically receive oxygen therapy at home through stationary oxygen concentrators and metal oxygen tanks, explains Douglas Gerlach, growth stock expert and editor of SmallCap Informer.
NEW YORK , Sept. 19, 2019 /PRNewswire/ -- Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City , is investigating potential claims involving the directors and officers ...
NEW YORK , Sept. 12, 2019 /PRNewswire/ -- Park Hotels & Resorts Inc. (NYSE: PK) will replace Inogen Inc. (NASD: INGN) in the S&P MidCap 400 and Inogen will replace Chesapeake Lodging Trust (NYSE: CHSP) ...